Effect of Enalapril therapy on left ventricular mass and volumes in asymptomatic chronic, severe mitral regurgitation secondary to mitral valve prolapse

American Journal of Cardiology

Volumn 82, Issue 2, 1998, Pages 242-245

  Tischler, Marc D ^a,b   Rowan, Michaelanne ^a   LeWinter, Martin M ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL;

ADULT; AGED; ARTICLE; BICYCLE ERGOMETRY; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HUMAN; MALE; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ULTRASOUND;

EID: 0032527942     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00325-7     Document Type: Article

References (17)

1. 1. Carabello B. The changing unnatural history of valvular regurgitation. Ann Thorac Surg 1992;53:191-199.
2. 2. Levine H, Gaasch W. Vasoactive drups in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol 1996;28:1083-1091.
3. 3. Helmcke F, Navin N, Hsiung M, Soto B, Adey CK, Goyal RG, Gatewood RP. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987;75:175-183.
4. 4. Blumlein S, Bouchard A, Schiller N, Dae M, Byrd BR, Ports T, Botvinick EH. Quantitation of mitral regurgitation by Doppler echocardiography. Circulation 1986;74:306-313.
5. 5. Lewis J, Kuo L, Limacher M, Quinones M. Pulsed-Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window. Circulation 1984;70:425-431.
6. 6. Marshall S, Weyman A. Doppler estimation of volumetric flow. In: Weyman A, ed. Philadelphia, PA: Lea and Febiger, 1994:971.
7. 7. Helak J, Reichek N. Quantification of human left ventricular mass and volume by 2-dimensional echocardiography: in vivo anatomic validation. Circulation 1981;63:1398-1407.
8. 8. St. John Sutton M, Plappert T, Spiegel A, Raichlen J, Douglas P, Reichek N, Edmunds L. Early postoperative changes in left ventricular chamber size, architecture, and function in aortic stenosis and aortic regurgitation and their relation to intraoperative changes in afterload: a prospective 2-dimensional echocardiographic study. Circulation 1987;76:77-89.
9. 9. Goodman D, Rossen R, Holloway E, Alderman E, Harrison D. Effect of nitroprusside on left ventricular dynamics in mitral regurgitation. Circulation 1974;50:1025-1032.
10. 10. Chatterjee K, Parmley W, Swan H, Berman G, Forrester J, Marcus H. Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvular apparatus. Circulation 1973;48:684-689.
11. 11. Greenberg B, Massie B, Brundage B, Botvinick E, Parmley W, Chatterjee K. Beneficial effects of hydralazine in severe mitral regurgitation. Circulation 1978; 58:273-279.
12. 12. Greenberg B, Demots H, Murphy E, Rahimtoola S. Arterial dilators in mitral regurgitation: effects on rest and exercise hemodynamics and long-term clinical follow-up. Circulation 1982;65:181-187.
13. 13. Wisenbaugh T, Essop R, Rothlissberger C, Sareli P. Effects of a single oral dose of captopril on left ventricular performance in severe mitral regurgitation. Am J Cardiol 1992;69:348-353.
14. 14. Rothlisberger C, Sareli P, Wisenbaugh T. Comparison of single dose nifedipine and captopril for chronic severe mitral regurgitation. Am J Cardiol 1994; 73:978-981.
15. 15. Schon H, Schroter G, Blomer H, Schlomig A. Beneficial effects of a single dose of quinapril on left ventricular performance in chronic mitral regurgitation. Am J Cardiol 1994;73:785-791.
16. 16. Jeang M, Petrovich L, Adyanthaya A, Alexander J. Effects of isosorbide dinitrate on rheumatic and non-rheumatic mitral regurgitation. J Texas Heart Inst 1986;13:453-457.
17. 17. Takenaka K, Sakamoto T, Amano. Effect of amyl nitrate on mitral valve prolapse and mitral regurgitation. Am J Noninvas Cardiol 1991;5:257-261.